nytimes June 22, 2021 4:00am Many Alzheimer’s Experts Say Use of Aduhelm Should Be Sharply Limited #yourfeedscience #alzheimersdisease #aduhelmdrug #drugspharmaceuticals #labelingandlabelsproduct #clinicaltrials #alzheimersassn #biogeninc #foodanddrugadministration #yourfeedhealthcare #news Many Alzheimer’s Experts Say Use of Aduhelm Should Be Sharply Limited Even those who supported the F.D.A.’s approval of the controversial new drug said authorizing it for anyone with Alzheimer’s disease was much too broad.
nytimes June 6, 2021 1:00am Alzheimer’s Drug Poses a Dilemma for the F.D.A. #alzheimersdisease #drugspharmaceuticals #clinicaltrials #elderly #memory #brain #aducanumabdrug #biogeninc #foodanddrugadministration #alzheimersassn #yourfeedscience #yourfeedhealthcare #news Alzheimer’s Drug Poses a Dilemma for the F.D.A. If the agency approves it, aducanumab would be the first new Alzheimer’s treatment since 2003. Patients are desperate for new options, but some scientists say there isn’t enough evidence it works.
